Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Morris

Showing results (321-330 of 334) with videos related to

Pageof 34
Sort By:
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
Editorial: How Will Aducanumab Approval Impact AD Research?M W Weiner, P S Aisen, L A Beckett, et al.
Oncogene|July 31, 1997
Characterization of murine Flt4 ligand/VEGF-CL J Fitz, J C Morris, P Towler, et al.
European Journal of Neurology|February 22, 2019
Tau positron emission tomography imaging in C9orf72 repeat expansion carriersC V Ly, L Koenig, J Christensen, et al.
Molecular Genetics and Metabolism|December 26, 2001
Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementiaM J Kovach, B Waggoner, S M Leal, et al.
Experimental Hematology|October 1, 1996
Molecular cloning and characterization of murine interleukin-11J C Morris, S Neben, F Bennett, et al.
JAMA|October 29, 1997
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyG W Small, P V Rabins, P P Barry, et al.
Nature Genetics|May 13, 1999
Alpha-2 macroglobulin gene and Alzheimer diseaseV Rudrasingham, F Wavrant-De Vrièze, J C Lambert, et al.
Neuroscience Letters|April 15, 1999
No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's diseaseF Wavrant-DeVrièze, V Rudrasingham, J C Lambert, et al.
Human Genetics|January 26, 2002
Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's diseaseR Abraham, A Myers, F Wavrant-DeVrieze, et al.
Neurology|July 10, 2002
Contribution of APOE promoter polymorphisms to Alzheimer's disease riskJ-C Lambert, L Araria-Goumidi, L Myllykangas, et al.
Pageof 34

Showing results (321-330 of 334) with videos related to

Sort By:
Pageof 34
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
Editorial: How Will Aducanumab Approval Impact AD Research?M W Weiner, P S Aisen, L A Beckett, et al.
Oncogene|July 31, 1997
Characterization of murine Flt4 ligand/VEGF-CL J Fitz, J C Morris, P Towler, et al.
European Journal of Neurology|February 22, 2019
Tau positron emission tomography imaging in C9orf72 repeat expansion carriersC V Ly, L Koenig, J Christensen, et al.
Molecular Genetics and Metabolism|December 26, 2001
Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementiaM J Kovach, B Waggoner, S M Leal, et al.
Experimental Hematology|October 1, 1996
Molecular cloning and characterization of murine interleukin-11J C Morris, S Neben, F Bennett, et al.
JAMA|October 29, 1997
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyG W Small, P V Rabins, P P Barry, et al.
Nature Genetics|May 13, 1999
Alpha-2 macroglobulin gene and Alzheimer diseaseV Rudrasingham, F Wavrant-De Vrièze, J C Lambert, et al.
Neuroscience Letters|April 15, 1999
No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's diseaseF Wavrant-DeVrièze, V Rudrasingham, J C Lambert, et al.
Human Genetics|January 26, 2002
Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's diseaseR Abraham, A Myers, F Wavrant-DeVrieze, et al.
Neurology|July 10, 2002
Contribution of APOE promoter polymorphisms to Alzheimer's disease riskJ-C Lambert, L Araria-Goumidi, L Myllykangas, et al.
Pageof 34